Delivery Order SPE2DB22D9353-SPE2DB25FX2AK
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $54.7K by the Defense Logistics Agency for the supply of Perjeta 420 mg/14 mL vials. The contract, awarded on July 30, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $27,343.62 by the Defense Logistics Agency (DLA) on July 25, 2025. The contract calls for the delivery of Perjeta 420 mg/14 ml vials, a targeted cancer therapy used in oncology treatments. This delivery order is issued without a set-aside designation and carries an ultimate completion date of August 15, 2025, with performance...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $8,509.92, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the oncology drug Perjeta (pertuzumab) 420 mg/14 mL vial, with an ultimate completion date of October 10, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth up to $25,529.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4563969889 - Perjeta 420 mg/14 ml vial, 14 ml, with a performance period through April 1, 2024. This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract SPE2DB24FSW68 with DLA, which has a ceiling value of up to...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty thousand six hundred ninety-two dollars and fifty cents ($20,692.50) by the Defense Logistics Agency to provide Perjeta 420 mg/14 ml vials. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. As a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $82,770.00 contract is for the supply of 4,560,409,012 units of Perjeta 420 mg/14 ml vial. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) under the SPE2DB program, which allows the DLA to issue fixed-price orders for a comprehensive range of...
- This firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $34,039.68, is for the delivery of the pharmaceutical product Perjeta (420 mg/14 ml vial, 14 ml) with a completion date of April 19, 2024. DMS Pharmaceutical Group holds a separate indefinite delivery contract with DLA, valued up to $4,999,999 through 2025, for a broad range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,764.88 firm fixed-price delivery order is for the supply of Perjeta 420 mg/14 ml vial (14 ml) to fulfill the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $25,529.76 contract is for the delivery of Perjeta, a 420 mg/14 ml vial oncology medication, with a period of performance through April 9, 2024. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract SPE2DB, a single-award contract valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $34,039.68 firm fixed-price delivery order is for the supply of Perjeta 420 mg/14 ml vials, with a period of performance through October 30, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2AKDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency valued at $4,557.26 for Perjeta 420 mg/14 ml vials. The award, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at approximately $500 million and extends through November 2026, enabling the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. The delivery order represents a routine pharmaceutical supply transaction within DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain. Perjeta (pertuzumab) is a biologic therapeutic used primarily in oncology treatment protocols, consistent with the contractor's portfolio of specialty medications and biologics supplied to military health facilities. The Park Ridge, Illinois location serves as the place of performance for this delivery order, leveraging the company's operational capacity as a longstanding federal pharmaceutical distributor registered in SAM.gov since 2001.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 7/31/25 |